Literature DB >> 26434493

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.

Jeffry Iman Gurnadi1, Johannes Mose2, Budi Handono3, Mieke H Satari4, Anita Deborah Anwar5, Prima Nanda Fauziah6, A Yogi Pramatirta7, Dwi Davidson Rihibiha8.   

Abstract

BACKGROUND: Placental soluble fms-like tyrosine kinase-1 (sFlt-1) which is an antagonist of vascular endothelial growth factor and placental growth factor (PIGF), is considered as one of etiology factors cause endothelial damage in preeclampsia due to increase of sFlt-1 level that change vascular endothelial integrity. This study aims to analyze the difference of sFlt-1 and PlGF concentration in severe preeclampsia and normal pregnancy, and the correlation between both in occurrence of severe preeclampsia.
METHOD: This is case control study involving 18 subjects with severe preeclampsia and 19 subjects with normal pregnancy as controls who met inclusion and exclusion criteria. Concentration of sFlt-1 and PlGF are measured with ELISA. Statistical analysis is performed with Chi square test, Fisher's exact test, T test, Mann-Whitney test, and Spearman's rank correlation test.
RESULTS: This study results in no significant difference in characteristics of gestational age, and parity in both study groups. Median concentration of sFlt-1 in severe preeclampsia is higher (20,524.75 pg/mL) compared with normal pregnancy (6820.4 pg/mL). Concentration of PlGF is lower in severe preeclampsia (47 pg/mL) compared with normal pregnancy (337 pg/mL). sFlt-1 concentration is higher in severe preeclampsia compared to normal pregnancy. PlGF concentration is lower in severe preeclampsia compared to normal pregnancy. Ratio of sFlt-1 and PlGF concentration is significantly correlated in both severe preeclampsia and normal pregnancy.
CONCLUSIONS: There is a significant negative correlation between the concentration of sFLt-1 and PlGF in normal pregnancy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26434493      PMCID: PMC4593222          DOI: 10.1186/s13104-015-1506-0

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  17 in total

Review 1.  New insights into the biology of preeclampsia.

Authors:  Holger Stepan; Renaldo Faber; Nadja Dornhöfer; Berthold Huppertz; Andrea Robitzki; Thomas Walther
Journal:  Biol Reprod       Date:  2006-01-18       Impact factor: 4.285

2.  Prediction of preeclampsia - a workshop report.

Authors:  N G Than; R Romero; R Hillermann; V Cozzi; G Nie; B Huppertz
Journal:  Placenta       Date:  2007-12-03       Impact factor: 3.481

3.  Angiogenesis factors and preeclampsia.

Authors:  Ralf Dechend; Friedrich C Luft
Journal:  Nat Med       Date:  2008-11       Impact factor: 53.440

4.  The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.

Authors:  P K Aggarwal; N Chandel; V Jain; V Jha
Journal:  J Hum Hypertens       Date:  2011-03-31       Impact factor: 3.012

5.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Authors:  Richard J Levine; Chun Lam; Cong Qian; Kai F Yu; Sharon E Maynard; Benjamin P Sachs; Baha M Sibai; Franklin H Epstein; Roberto Romero; Ravi Thadhani; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

6.  Hypertension in pregnancy.

Authors:  Marshall D Lindheimer; Sandra J Taler; F Gary Cunningham
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

7.  Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

Authors:  Yang Gu; David F Lewis; Yuping Wang
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

Review 8.  Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.

Authors:  Hernan D Kopcow; S Ananth Karumanchi
Journal:  J Reprod Immunol       Date:  2007-05-09       Impact factor: 4.054

9.  Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

Authors:  Vassilis Tsatsaris; Frederic Goffin; Carine Munaut; Jean-François Brichant; Marie-Rose Pignon; Agnes Noel; Jean-Pierre Schaaps; Dominique Cabrol; Francis Frankenne; Jean-Michel Foidart
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

Review 10.  Molecular mechanisms of preeclampsia.

Authors:  Walter P Mutter; S Ananth Karumanchi
Journal:  Microvasc Res       Date:  2007-05-06       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.